Serie: Resveratrol

Zu den Quellen

Resol + Buch zum Sonderpreis bestellen *


20% Rabatt-Code im ausgewählten Darm-Shop *



Paul, B., et al., Occurrence of resveratrol and pterostilbene in age-old Darakchasava, an Ayurvedic medicine from India. J. Ethnopharmocol. 68 (1999) 71-76. 

Renaud, S., de Lorgeril, M., Wine, Alcohol, Platelets and the French Paradox for Coronary Heart Disease. Lancet 339 (1992) 1523-1526. 

Ignatowicz, E., Baer-Dubowska, W., Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol. J. Pharmacol. 53 (6) (2001) 557-569. 

Criqui, M. H., Ringel, B. L., Does Diet or Alcohol Explain the French Paradox? Lancet 344 (1994) 1719-1723. 

Hung, L. M., et al., Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47 (2000) 549-555. 

Klatsky, A. L., Armstrong, M. A., Friedman, G. D., Red wine, white wine, liquor, beer and risk for coronary artery disease hospitalization. Am. J. Cardiol. 80 (1997) 416-420. 

Gronbaek, M., et al., Mortality Associated with Moderate Intakes of Wine, Beer, or Spirits. Brit. Med. J. 310 (1995) 1165-1169. 

Gould, K. S., Nature´s Swiss Army Knife: The Diverse Protective Roles of Anthocyanins in Leaves. J. Biomed. Biotechnol. 5 (2004) 314-320. 

Leonard, S., et al., Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 309 (2003) 1017-1026. 

Martinez, J., Moreno, J. J., Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59 (2000) 865-870. 

Steinberg, D., et al., Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924. 

Frankel, E. N., Waterhouse, A. L., Kinsella, J. E., Inhibition of human LDL oxidation by resveratrol. Lancet 341 (1993) 1103-1104. 

Olas, B., et al., Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochem. Pol. 46 (1999) 961-966. 

Virgili, M., Contestabile, A., Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett. 281 (2000) 123-126. 

Savaskan, E., et al., Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 49 (2003) 380-383. 

Willerson, J. T., Ridker, P. M., Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10. 

McGeer, E. G., McGeer, P. L., Inflammatory processes in Alzheimer`s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749. 

Philip, M., Rowley, D. A., Schreiber, H., Inflammation as a tumor promoter in cancer induction. Semin. Cancer Biol. 14 (2004) 433-439. 

Subbaramaiah, K., et al., Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann. NY Acad. Sci. 889 (1999) 214-22. 

Tsai, S. H., Lin-Shiau, S. Y., Lin, J. K., Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Brit. J. Pharmacol. 126 (1999) 673-680. 

Kundu, J. K., Surh, Y.-J., Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat. Res. 555 (2004) 65-80. 

Jang, M. S., et al., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220. 

Marx, J., Cancer research. Inflammation and cancer: the link grows stronger. Science 306 (2004) 966-968. 

Dorrie, J. C., et al., Resveratrol induces extensive apoptosis by depolarizing mitchondrial membranes and activating caspase-9 in acute lymphoblastic leukaemia cells. Cancer Res. 61 (2001) 4731-4739. 

Mahyar-Roemer, M., Kohler, H., Roemer, K., Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer 2 (2002) 27-36. 

Fulda, S., Debatin, K. M., Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 64 (2004) 337-346. 

Aggarwal, B. B., et al., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24 (2004) 2783-2840. 

McCay, C. M., Cromwell, M. F., Maynard, L. A., The Effect of retarded growth upon the length of life span upon the ultimate body size. J. Nutr. 10 (1935) 63-79. 

Lin, S. J., Defossez, P. A., Guarente, L., Requirement of NAD and SIR 2 for lifespan extension by calorie restriction in Saccharomyces cerevisiae. Science 289 (2000) 2126-2128. 

Anderson, R. M., et al., Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423 (2003) 181-185. 

Langley, E., et al., Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21 (2002) 2383-2396. 

Howitz, K. T., et al., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196. 

Wood, J. G., et al., Sirtuin activators mimic calorie restriction and delay ageing in metazoans. Nature 430 (2004) 686-689. 

Araki, T., Sasaki, Y., Milbrandt, J., Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013. 

Baur, J. A., et al., Resveratrol improves health and survival of mice on a high-calorie diet. Nature Vol. 444 (2006) 337-342. 

Walle, T., et al., High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32 (2004) 1377-1382. 

Mertens-Talcott, S. U., Percival, S. S., Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 218 (2005) 141-152. 

Pervaiz, S., Reveratrol. From grapevines to mammalian biology. FASEB J. 17 (2003) 1975-1985. 

Crowell, J. A., et al., Resveratrol-associated renal toxicity. Toxicol. Sciences 82 (2004) 614-619.